FOR ADULTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS (RA), IN COMBINATION WITH METHOTREXATE (MTX)

WHAT OCCUPIES YOUR MIND?

References: 1. SIMPONI ARIA® (golimumab) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc. 2. Weinblatt ME, Bingham CO III, Mendelsohn AM, et al. Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial. Ann Rheum Dis. 2013;72:381-389. 3. Data on file. Janssen Biotech, Inc.

TRICARE is a registered trademark of the Department of Defense (DoD), DHA.